Alzheimer's disease and oxygen radicals:: new insights

被引:153
作者
Praticò, D [1 ]
机构
[1] Univ Penn, Sch Med, Ctr Expt Therapeut, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
Alzheimer's disease; oxygen free radicals; oxidative stress; isoeicosanoids; amyloid; transgenic animals;
D O I
10.1016/S0006-2952(01)00919-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Alzheimer's disease (AD) is the most common form of neurodegenerative disease, with dementia, in the elderly. In addition to the presence of senile plaques and neurofibrillary tangles, the AD brain exhibits evidence for oxygen radical-mediated damage, a situation commonly known as oxidative stress. However, the ability to directly implicate this mechanism in AD has been a difficult task for several reasons. First, most of the analytical approaches used to investigate oxidative stress turned out to be unreliable. Second, the majority of the published studies have been performed in post-mortem tissues with advanced disease, leaving open the question as to whether oxidative stress is an early event or a common final step secondary to the degenerative process. The discovery of the isoprostanes, recent studies performed in living patients, and the development of transgenic animal models of AD-amyloidosis are three important factors that are helping us to better understand and define the role that oxygen radicals might play in AD pathogenesis. Here we review some of the most recent works that have supported the importance of oxygen radical-mediated damage in AD. The accumulated information points toward an earlier involvement than previously thought of oxidative stress in the pathogenesis of the disease, making this a potential target for therapeutic intervention, especially in subjects at high risk for developing AD. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:563 / 567
页数:5
相关论文
共 38 条
[21]   Increased CSF F2-isoprostane concentration in probable AD [J].
Montine, TJ ;
Beal, MF ;
Cudkowicz, ME ;
O'Donnell, H ;
Margolin, RA ;
McFarland, L ;
Bachrach, AF ;
Zackert, WE ;
Roberts, LJ ;
Morrow, JD .
NEUROLOGY, 1999, 52 (03) :562-565
[22]   SELECTIVE INCREASE IN LIPID-PEROXIDATION IN THE INFERIOR TEMPORAL CORTEX IN ALZHEIMERS-DISEASE [J].
PALMER, AM ;
BURNS, MA .
BRAIN RESEARCH, 1994, 645 (1-2) :338-342
[23]  
Pappolla MA, 1998, AM J PATHOL, V152, P871
[24]   Oxidative injury in diseases of the central nervous system:: Focus on Alzheimer's disease [J].
Praticò, D ;
Delanty, N .
AMERICAN JOURNAL OF MEDICINE, 2000, 109 (07) :577-585
[25]   F2-isoprostanes:: sensitive and specific non-invasive indices of lipid peroxidation in vivo [J].
Praticò, D .
ATHEROSCLEROSIS, 1999, 147 (01) :1-10
[26]  
Praticó D, 2000, ANN NEUROL, V48, P795, DOI 10.1002/1531-8249(200011)48:5<795::AID-ANA15>3.3.CO
[27]  
2-R
[28]   In vivo measurement of the redox state [J].
Praticò, D .
LIPIDS, 2001, 36 :S45-S47
[29]   The isoprostanes in biology and medicine [J].
Praticò, D ;
Lawson, JA ;
Rokach, J ;
FitzGerald, GA .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2001, 12 (06) :243-247
[30]   Increased F2-isoprostanes in Alzheimer's disease:: evidence for enhanced lipid peroxidation in vivo [J].
Praticò, D ;
Lee, VMY ;
Trojanowski, JQ ;
Rokach, J ;
Fitzgerald, GA .
FASEB JOURNAL, 1998, 12 (15) :1777-1783